Skip to content

The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy

Art Van Zee

American Journal of Public Health · 2008 · 976 citationsOpen access

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Zee, A. V. (2008). The promotion and marketing of OxyContin: Commercial triumph, public health tragedy. American Journal of Public Health, 99(2), 221–227. https://doi.org/10.2105/ajph.2007.131714

In text: (Zee, 2008)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

I focus on issues surrounding the promotion and marketing of controlled drugs and their regulatory oversight. Compared with noncontrolled drugs, controlled drugs, with their potential for abuse and diversion, pose different public health risks when they are overpromoted and highly prescribed. An in-depth analysis of the promotion and marketing of OxyContin illustrates some of the associated issues. Modifications of the promotion and marketing of controlled drugs by the pharmaceutical industry and an enhanced capacity of the Food and Drug Administration to regulate and monitor such promotion can have a positive impact on the public health.

  1. Comorbidity of Mental Disorders With Alcohol and Other Drug Abuse1990
  2. CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 20162016
  3. Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century2015
  4. Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults — United States, 20162018
  5. Self-injurious thoughts and behaviors as risk factors for future suicide ideation, attempts, and death: a meta-analysis of longitudinal studies2015

Metadata from OpenAlex (CC0). Citations are generated from the published record.